![Building trust with consumers is critical for brands](/content/images/size/w1304/format/webp/2024/08/2022_Meijer_Own_Brand_Customer.jpg)
Building trust with consumers is critical for brands
Trust is crucial for achieving customer loyalty and repeat purchases, as well as creating brand evangelists, and authenticity is a cornerstone of building consumer trust.
Trust is crucial for achieving customer loyalty and repeat purchases, as well as creating brand evangelists, and authenticity is a cornerstone of building consumer trust.
The recent release of an interim report by the Federal Trade Commission about what the agency characterizes as “prescription drug middlemen” represents a vindication of sorts for pharmacy advocates who have long contended that PBMs employ business practices that skew the market to their advantage.
At the same time, consumers’ heightened expectations of their shopping experience have shifted over the past five years, with more ways in which to discover, compare and purchase products.
In today’s complex environment, understanding the nuances driving associate behavior is not just an option — it’s an imperative. Chain drug stores must explore the strategies that simultaneously promote the factors driving retention while reducing the factors that influence decisions to leave.
The drivers of connection with shoppers are the products you offer, the convenience you provide and the value you deliver.
While many people might think of OOH as static billboards on a highway, it’s evolved to be much more dynamic than that, giving brands privacy-compliant but effective and noninvasive ways to reach consumers.
However, many of the practices and strategies being used to drive growth are either home grown or are being transferred from other rich countries.
Traditionally, linear TV has been a mainstay of advertising investments for pharma marketers, but now consumers are increasingly shifting their time towards CTV and streaming.
As we delve deeper into this transformative era, it’s essential to understand and embrace the potential of GenAI in revolutionizing patient care, ensuring that those who invest are well informed and poised to reap substantial benefits.
As consumers and the health care industry continue to embrace digital transformation, the rise of Amazon Pharmacy signals a significant threat to established pharmacy models.
Over the past few years, we’ve seen a transformation in the alignment with consumer behavior toward streaming environments.
Traditionally, the process of discovering and developing new drugs has been lengthy and expensive, often taking over a decade and billions of dollars. AI can streamline this process in four key ways.
According to an Accenture report, “The Empowered Consumer,” retailers and brands have inadvertently created a cacophony of choice that could result in lost revenue.
The opportunities to keep boomers youthful are only limited by an entrepreneur’s imagination.
NACDS continues to advocate vigorously — and in ever more bold ways — for federal and state policies that are absolutely essential for health and wellness innovation.